GSK Plc
NYSE: GSK
$33.96
-$0.11 (-0.3%)
Real Time Data Delayed 15 Min.
GSK Articles
The three major US stock indexes opened lower this morning following some lackluster data on the US economy. The Empire State manufacturing data improved, but retail sales posted an unexpected...
Published:
Last Updated:
What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to wonder which other peers and competitors might be on the M&A block. Monday’s...
Published:
Last Updated:
Updated throughout the day on the 24/7 Wall St. Wire: GlaxoSmithKline (NYSE: GSK) will buy Human Genome Sciences (NASDAQ: HGSI) for $2.8 billion. (Reuters) The Justic Department and HSBC (NYSE: HBC)...
Published:
Much of the financial future of Europe is still caught in a web of the political movements of Germany’s Angela Merkel. Today, the possibility that her own party will not support a Spanish bank...
Published:
GlaxoSmithKline (NYSE: GSK) will take over Human Genome Sciences (NASDAQ: HGSI) for $2.8 billion. (Reuters) A poll from the National Association for Business Economics shows few companies plan to...
Published:
More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks associated with future regulation under health care, but deals in the biotech and emerging...
Published:
Last Updated:
The freshly announced multibillion biotech buyout of Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) for more than $5 billion in equity value may be a bit misleading if you consider that it is...
Published:
Last Updated:
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released their most recent U.S.-listed equity holdings for the Berkshire Hathaway empire. This cut off date is as of March...
Published:
Last Updated:
Coalition talks in Greece are unlikely to create a new government, raising the chance Greece could leave the eurozone. (Reuters) GlaxoSmithKline (NYSE: GSK) will launch a takeover of Human Genome...
Published:
A judge objects to parts of an AIG (NYSE: AIG) suit to block a Bank of America (NYSE: BAC) settlement over mortgage bond sales. (Reuters) Apple’s (NASDAQ: AAPL) earnings are better than even the...
Published:
Theravance Inc. (NASDAQ: THRX) got a big boost today from a purchase of 10 million additional shares by GlaxoSmithKline plc (NYSE: GSK) at a 7.5% premium to a volume-weighted average share price for...
Published:
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released the latest holdings of U.S.-listed equities as of December 30, 2011. These public stock holdings have been broken...
Published:
Last Updated:
The tide of patent expirations that is washing over big pharmaceutical houses is cresting now and investors have begun looking forward to how these companies will deal with some sharp blows to their...
Published:
Last Updated:
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released the latest holdings of U.S.-listed equities as of September 30, 2011. These public stock holdings have been broken...
Published:
Last Updated: